Male Cancer Awareness Week Press Release

Diagnosis of late-stage prostate cancer reaches all-time high

As the latest figures show that 42.5% of diagnoses of prostate cancer are made in the late stages (stages iii or iv)[i], men’s cancer charity Orchid is calling for men and healthcare professionals to FACE up to the disease.

The latest figures follow a 5-year trend and are coupled with statistics from a survey[ii], commissioned by Orchid, which are being released for Male Cancer Awareness Week (2nd – 8th September) and highlight that awareness of prostate cancer risk factors amongst GPs is worryingly low, particularly in relation to ethnicity and family history:

  • Only 5% named ethnicity as a primary risk factor, despite black African and black Caribbean men being twice as likely to develop the disease as other men
  • Less than half of all GPs surveyed recognised that family history and age are risk factors, despite family history potentially doubling a man’s risk and incidence being highest in the over 50’s
  • 15% of GPs mistakenly thought infections such as HPV were a primary risk factor for prostate cancer

Orchid’s Chief Executive, Rebecca Porta is calling on GPs to consider prostate cancer risk even before men present with symptoms. “We know from previous research that 60% of men are not confident in recognising the symptoms of prostate cancer and 31% have no knowledge of the disease so the GP-patient interface is essential to reverse the continued increase in late stage diagnosis.  Whilst we appreciate that GP time is limited, we urge them to incorporate a prostate cancer awareness discussion into every consultation with at-risk men”.

Late diagnosis can reduce chances of survival, limit treatment options or result in more invasive interventions. Orchid’s F.A.C.E. up to prostate cancer campaign is therefore encouraging GPs, men and their families to be aware of four key risk factors and for men and their family doctor to discuss any concerns in order to achieve earlier stage diagnosis.

Family history – having a brother or father with prostate cancer may double a man’s risk compared to men with no family history of the disease.

 

Age – the older a man gets the greater the risk, with prostate cancer most commonly affecting men over the age of 50.

 

Change in urinary habits – changes in urinary habits are not always a sign of prostate cancer but they can be a symptom.

 

Ethnicity – black African and black Caribbean men are at double the risk of developing prostate cancer than other men and may develop the disease earlier too, most commonly affecting men from this group over 45.

 

[i] National Cancer Registration and Analysis Service (2019) Stage breakdown by CCG 2017: TNM stage group by CCG by tumour type for 10+3 tumour types, 2012-2017 Available at: http://www.ncin.org.uk/publications/survival_by_stage (Accessed: 12 August 2019).

[ii] Orchid – Fighting Male Cancer. (Aug. 2019). Prostate Cancer: Survey of GPs. Censuswide. The survey was conducted from a sample of 100 UK GPs. Censuswide abide by and employ members of the Market Research Society which is based on the ESOMAR principles.

 

 

 

GP responses to the question: In your opinion, what are the primary risk factors associated with prostate cancer that men should be most aware of?

 

 

Notes to Editors

Orchid presents the latest data regarding prostate cancer in its annual ‘Prostate Cancer: Situation Report 2019’ which will be published during Orchid’s Male Cancer Awareness Week (2nd – 8th September 2019). A copy of the  the ‘F.A.C.E.’ graphic is available to download here

 

Experts available for interview:

 

  • Rebecca Porta – Orchid Chief Executive
  • Rob Cornes – Orchid Male Cancer Information Nurse

 

 

Prostate cancer

Prostate cancer is the most common male cancer with over 47,700 cases diagnosed per year. Prostate cancer kills more than 1 man an hour in the UK equating to 11,600 men every year.

 

Orchid

Orchid is the UK’s leading registered charity focused exclusively on male-specific cancers. Formed in 1996 by a testicular cancer patient, Orchid exists to save men’s lives from testicular, prostate, and penile cancers through pioneering research, the provision of specialist information and support, campaigns and raising awareness. www.orchid-cancer.org.uk

 

For further information, expert interviews or copies of the report please contact:

 

[1] National Cancer Registration and Analysis Service (2019) Stage breakdown by CCG 2017: TNM stage group by CCG by tumour type for 10+3 tumour types, 2012-2017 Available at: http://www.ncin.org.uk/publications/survival_by_stage (Accessed: 12 August 2019).

[1] Orchid – Fighting Male Cancer. (Aug. 2019). Prostate Cancer: Survey of GPs. Censuswide. The survey was conducted from a sample of 100 UK GPs. Censuswide abide by and employ members of the Market Research Society which is based on the ESOMAR principles.

Was this page useful?

  • Please type the code above, so you can submit the form.
  • This field is for validation purposes and should be left unchanged.